Trump announces nationwide Medicaid drug deal

President Trump will announce Friday that all 50 states are joining the Medicaid GENEROUS model, which ties U.S. drug prices to the lowest prices paid in other wealthy countries.

White House projects $529 billion savings

The Trump administration estimates the program will save $529 billion over the next 10 years by negotiating lower prescription drug prices with pharmaceutical companies.

Secret deals block independent verification

Few details of the agreements between the Trump administration and pharmaceutical companies have been made public, making it impossible for experts to independently verify the claimed savings.

“No one knows what is in these deals.”

Policy experts demand more transparency

Kathy Hempstead from the Robert Wood Johnson Foundation says Congress needs granular data to justify the cost-savings claims and to consider codifying the pricing arrangements into law.

“He is saying Congress should codify all of his MFN arrangements. But it's kind of unreasonable because it's not clear what Congress would actually do.”

Concerns about program longevity

Experts worry that price cuts may not survive beyond the Trump administration, potentially reverting to higher levels once the current administration leaves office.

Progress incomplete for uninsured Americans

Pharmaceutical reform advocates say the announcement shows progress but millions of Americans without government healthcare coverage still lack access to lower drug prices.

“meaningful progress, but that progress remains incomplete”